// App-Quantinova.ai

: Cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of TAVI associated acute kidney injury

Researchers

Presenter

  • G.F. Filardo

Principal Investigators

  • C.W.H. Hamm

  • T.W. Walther

  • W.K.K. Kim

  • C. Liebetrau

Medical Centers

  • Baylor University Medical Center, Cardiovascular Epidemiology, Dallas, United States of America

  • Kerckhoff Heart and Thorax Center, Department of Cardiology, Bad Nauheim, Germany

  • Kerckhoff Heart and Thorax Center, Thoracic Surgery, Bad Nauheim, Germany

  • Kerckhoff Heart Center, Bad Nauheim, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • N/A

Biomarkers

  • Creatinine

  • Cystatin C

  • Lipocalin 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A